Recruitment of CD8+ T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1+ in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation

Annals of Hematology

Volumn 94, Issue 10, 2015, Pages 1689-1698

  Zhang, Xiao Hui ^a   Wang, Guo Xiang ^a   Zhu, Hong Hu ^a   Liu, Yan Rong ^a   Xu, Lan Ping ^a   Han, Wei ^a   Chen, Huan ^a   Chen, Yu Hong ^a   Wang, Feng Rong ^a   Wang, Jing Zhi ^a   Wang, Yu ^a   Zhao, Ting ^a   Chen, Yao ^a   Feng, Ru ^a   Fu, Hai Xia ^a   Wang, Min ^a   Zhou, Yi ^a   Lv, Meng ^a   Liu, Kai Yan ^a   Huang, Xiao Jun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

CD8+ T cell; CX3CR1+; Megakaryocyte; Stem cell transplantation; Thrombocytopenia

Indexed keywords

CYCLOSPORIN A; FAS ANTIGEN; FOSCARNET; FRACTALKINE; GANCICLOVIR; METHOTREXATE; MYCOPHENOLATE MOFETIL; THYMOCYTE ANTIBODY; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, HUMAN;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APOPTOSIS; ARTICLE; BLOOD SAMPLING; BONE MARROW; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MEGAKARYOPOIESIS; PATHOGENESIS; PLOIDY; PRIORITY JOURNAL; PROLONGED ISOLATED THROMBOCYTOPENIA; RISK FACTOR; T CELL DEPLETION; T LYMPHOCYTE SUBPOPULATION; THROMBOCYTOPENIA; ADOLESCENT; ADVERSE EFFECTS; ALLOTRANSPLANTATION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; APOPTOSIS; BONE MARROW; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MEGAKARYOCYTES; MIDDLE AGED; RECEPTORS, CHEMOKINE; THROMBOCYTOPENIA; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84941012482     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-015-2436-6     Document Type: Article

References (38)

1. Zhang X et al (2011) Prolonged thrombocytopenia following allogeneic hematopoietic stem cell transplantation and its association with a reduction in ploidy and an immaturation of megakaryocytes. Biol Blood Marrow Transplant 17(2):274–280
2. Yamazaki R et al (2006) Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover. Bone Marrow Transplant 38(5):377–384
3. Kong Y et al (2014) Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20(8):1190–1197
4. Kim DH et al (2006) Prognostic significance of platelet recovery pattern after allogeneic HLA-identical sibling transplantation and its association with severe acute GVHD. Bone Marrow Transplant 37(1):101–108
5. Poon LM et al (2013) Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation. Am J Blood Res 3(3):260–264
6. Shono Y et al (2014) Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20(4):495–500
7. Pihusch R et al (2002) Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation 74(9):1303–1309
8. Nash RA et al (1996) The problem of thrombocytopenia after hematopoietic stem cell transplantation. Stem Cells 14(Suppl 1):261–273
9. Nakamae H et al (2011) Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs. Haematologica 96(12):1838–1845
10. Ronghe MD et al (2002) The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation. Br J Haematol 118(4):1124–1127
11. Bruno B et al (2001) Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7(3):154–162
12. Reid R et al (2012) Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia. Am J Hematol 87(7):743–745
13. Mattia G et al (2002) Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 99(3):888–897
14. Patel SR, Hartwig JH, Italiano JE Jr (2005) The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 115(12):3348–3354
15. De Botton S et al (2002) Platelet formation is the consequence of caspase activation within megakaryocytes. Blood 100(4):1310–1317
16. Li S et al (2007) CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura. Br J Haematol 139(4):605–611
17. Houwerzijl EJ et al (2006) Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death. Leukemia 20(11):1937–1942
18. Olsson B et al (2008) Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1. Blood 112(4):1078–1084
19. Brissot E et al (2015) Involvement of the CX3CL1 (fractalkine)/CX3CR1 pathway in the pathogenesis of acute graft-versus-host disease. J Leukoc Biol 97(2):227–235
20. Zhang Y et al (2005) Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. J Immunol 174(5):3051–3058
21. Imai T et al (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91(4):521–530
22. Wang Y et al (2013) Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Cancer 119(5):978–985
23. Chang YJ, Huang XJ (2014) Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers. Bone Marrow Transplant 49(7):873–879
24. Tomer A (2004) Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes. Blood 104(9):2722–2727
25. Mick R, Williams SF, Bitran JD (1990) Patients at increased risk for late engraftment after transplantation: a novel method for their identification. Bone Marrow Transplant 6(3):185–191
26. Anasetti C et al (1989) Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood 73(4):1054–1058
27. Sivakumaran M et al (1995) Thrombocytopenia following autologous bone marrow transplantation: evidence for autoimmune aetiology and B cell clonal involvement. Bone Marrow Transplant 15(4):531–536
28. Kim DH et al (2006) Clinical significance of platelet count at day +60 after allogeneic peripheral blood stem cell transplantation. J Korean Med Sci 21(1):46–51
29. Bolwell B et al (2004) Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant. Bone Marrow Transplant 33(4):419–423
30. Umehara H et al (2004) Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 24(1):34–40
31. Yoneda O et al (2000) Fractalkine-mediated endothelial cell injury by NK cells. J Immunol 164(8):4055–4062
32. Di Rosa F, Pabst R (2005) The bone marrow: a nest for migratory memory T cells. Trends Immunol 26(7):360–366
33. Tomer A et al (1989) Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts. Blood 74(2):594–601
34. Falcieri E et al (2000) Ultrastructural characterization of maturation, platelet release, and senescence of human cultured megakaryocytes. Anat Rec 258(1):90–99
35. White MJ, Kile BT (2010) Apoptotic processes in megakaryocytes and platelets. Semin Hematol 47(3):227–234
36. Spencer A, Jackson J, Baulch-Brown C (2001) Enumeration of bone marrow ‘homing’ haemopoietic stem cells from G-CSF-mobilised normal donors and influence on engraftment following allogeneic transplantation. Bone Marrow Transplant 28(11):1019–1022
37. Italiano JE Jr, Shivdasani RA (2003) Megakaryocytes and beyond: the birth of platelets. J Thromb Haemost 1(6):1174–1182
38. Geddis AE (2009) The regulation of proplatelet production. Haematologica 94(6):756–759